• Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to secondary navigation

Before Header

Association of National Account Executives

Connect - Convene - Collaborate

  • About ANAE
    • Our Mission
    • Contact Us
  • News
    • Subscribe
    • Current Issue
    • Archive
  • Education & Content
    • Webinars
    • Blog
    • National Accounts University
    • Compensation Report
    • Whitepapers
  • Events
    • Events
    • Event Photos
  • Join ANAE
  • Login
  • About ANAE
    • Our Mission
    • Contact Us
  • News
    • Subscribe
    • Current Issue
    • Archive
  • Education & Content
    • Webinars
    • Blog
    • National Accounts University
    • Compensation Report
    • Whitepapers
  • Events
    • Events
    • Event Photos
  • Join ANAE
  • Login
  • Home
  • National Accounts Weekly
  • Events
  • Webinars
  • Join ANAE
  • Contact Us

The U.S. Drug Supply Chain in Crisis: Solutions to Shortages

One of the biggest challenges facing the U.S. healthcare system is drug shortages, with the potential for year over year growth to exceed 27%. 

The U.S. Food and Drug Administration’s Drug Shortages Task Force released a report that identified several factors that often converge to create a shortage situation, including:
-The lack of incentives for manufacturers to produce low-margin drugs,
-The market failing to recognize and reward manufacturers with robust quality control, and
-Regulatory and logistic issues that impede the market’s recovery after a shortage.
Read More
Previous Post: « Healthcare earnings reports from the first quarter of 2020
Next Post: The COVID-19 pandemic will have a long-term impact on healthcare. Here are 4 changes to expect »
  • Home
  • National Accounts Weekly
  • Events
  • Webinars
  • Join ANAE
  • Contact Us

Copyright © 2025 Association of National Account Executives · All Rights Reserved · Powered by Mai Theme